On May 11, 2022, the Board of Directors of the Company granted stock options to purchase 12,000 shares of the Company’s common stock to Alex Tabatabai, Chairman and Chief Executive Officer of the Company, and stock options to purchase 10,000 shares of the Company’s common stock to Adam Kopelman, Senior Vice President of Sales, Operations, and Strategic Initiatives of the Company, in each case at an exercise price of $4.10 per share, vesting in three equal annual installments beginning with the first anniversary of the grant date, as part of their compensation.